Imagine a world where early cancer detection is within everyone’s reach, potentially saving lives and reducing healthcare costs. Hear how MedX is making this vision a reality with its innovative skin cancer detection technology, and the profound impact it had on a single mother misdiagnosed by multiple doctors.

00:00 Technology and Healthcare Revolution
02:56 AI’s Role in Diagnostics
06:44 Introducing MedX: Early Skin Cancer Diagnosis
09:05 MedX: Process and Efficiency
11:11 MedX in Occupational Health
13:51 Cost-Effectiveness of Early Detection
15:56 MedX Device: Case Study
19:14 MedX Technology and Patient Workflow
24:29 Market Adoption and Accessibility
28:34 Teledermatology Workflow and Future Outlook
33:27 AI for Quality Control and Diagnostics

• Abbass on AI: “I think this is going to change medicine completely and I think that physicians and patients need to acknowledge this and be ready for these changes.”
• Mike Druhan “Cancer doesn’t wait, why should you?”
• Mike Druhan “We wanted to be able to get a large number of throughput patients to the dermatologist…But at the end we wanted the decision maker to be the dermatologist.”

Mike Druhan shares the journey of MedX from a company with technology “sitting in a box” to a leader in teledermatology, driven by the need for accessible and accurate skin cancer detection. The story highlights the challenges in healthcare adoption, the importance of collaboration with dermatologists, and the potential for AI to enhance quality control in medical imaging.

What do you think about AI in healthcare? Drop your thoughts below! 👇
Get in Touch!

rob@2docstocpodcast.com